종양 억제제 WT1은 전사를 억제하고 활성화합니다.이 유전자에 의해 암호화된 단백질은 WT1-상호작용 단백질로, 그 자체가 전사억제제 역할을 한다.WT1의 아연 핑거 DNA 결합 도메인과 상호작용하는 추정 류신 지퍼 도메인을 포함한다.이 단백질은 특히 전립선 [5]세포의 세포사멸 동안 상향 조절된다.Par-4 단백질의 활성 도메인은 정상적인 생존력이나 노화를 저해하지 않고 유전자 변환 생쥐에서 암 내성을 부여하는 것으로 밝혀졌으며 치료적[6]의미를 가질 수 있다.
El-Guendy N, Rangnekar VM (Feb 2003). "Apoptosis by Par-4 in cancer and neurodegenerative diseases". Experimental Cell Research. 283 (1): 51–66. doi:10.1016/S0014-4827(02)00016-2. PMID12565819.
Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP (Aug 1998). "Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease". Nature Medicine. 4 (8): 957–62. doi:10.1038/nm0898-957. PMID9701251. S2CID1621858.
Johnstone RW, Tommerup N, Hansen C, Vissing H, Shi Y (Oct 1998). "Mapping of the human PAWR (par-4) gene to chromosome 12q21". Genomics. 53 (2): 241–3. doi:10.1006/geno.1998.5494. PMID9790775.
Chakraborty M, Qiu SG, Vasudevan KM, Rangnekar VM (Oct 2001). "Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression". Cancer Research. 61 (19): 7255–63. PMID11585763.
Chang S, Kim JH, Shin J (Jan 2002). "p62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes PAR-4-induced PKCzeta inhibition". FEBS Letters. 510 (1–2): 57–61. doi:10.1016/S0014-5793(01)03224-0. PMID11755531. S2CID85579338.
Ohki R, Yamamoto K, Mano H, Lee RT, Ikeda U, Shimada K (Apr 2002). "Identification of mechanically induced genes in human monocytic cells by DNA microarrays". Journal of Hypertension. 20 (4): 685–91. doi:10.1097/00004872-200204000-00026. PMID11910304. S2CID34968458.
Hsu SC, Kirschenbaum F, Miller J, Cordell B, McCarthy JV (Jul 2002). "Structural and functional characterization of the upstream regulatory region of the human gene encoding prostate apoptosis response factor-4". Gene. 295 (1): 109–16. doi:10.1016/S0378-1119(02)00826-0. PMID12242017.
Boehrer S, Chow KU, Ruthardt M, Hoelzer D, Mitrou PS, Weidmann E (Sep 2002). "Expression and function of prostate-apoptosis-response-gene-4 in lymphatic cells". Leukemia & Lymphoma. 43 (9): 1737–41. doi:10.1080/1042819021000006510. PMID12685825. S2CID45232765.